Get started
Author

Ekaterina Stepanova

Observed names: E. A. Stepanova, E. А. Stepanova, Ekaterina A. Stepanova, Ekaterina A. Stepanova, Stepanova, Ekaterina
ORCID: 0000-0002-8670-8645
Observed ORCID: 0000-0002-8670-8645
OpenAlex ID: A5044164358
Influenza vaccine: progress in a vaccine that elicits a broad immune response
2021 · Irina Isakova-Sivak, Ekaterina Stepanova, et al. · Expert Review of Vaccines · 35
Detection of IFNγ-Secreting CD4+ and CD8+ Memory T Cells in COVID-19 Convalescents after Stimulation of Peripheral Blood Mononuclear Cells with Live SARS-CoV-2
2021 · Victoria Matyushenko, Irina Isakova-Sivak, et al. · Viruses · 32
PDF
Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model
2018 · Larisa Rudenko, Irina Kiseleva, et al. · PLoS ONE · 25
Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector
2022 · Irina Isakova-Sivak, Ekaterina Stepanova, et al. · Vaccines · 20
PDF
Recombinant Live Attenuated Influenza Vaccine Viruses Carrying Conserved T Cell Epitopes of Human Adenoviruses Induce Functional Cytotoxic T Cell Responses and Protect Mice against both Infections
2020 · Irina Isakova-Sivak, Victoria Matyushenko, et al. · Vaccines · 20
PDF
Ferristatin II Efficiently Inhibits SARS-CoV-2 Replication in Vero Cells
2022 · Alexey Sokolov, Irina Isakova-Sivak, et al. · Viruses · 17
PDF
Prospects of and Barriers to the Development of Epitope-Based Vaccines against Human Metapneumovirus
2020 · Ekaterina Stepanova, Victoria Matyushenko, et al. · Pathogens · 17
PDF
Overview of human rhinovirus immunogenic epitopes for rational vaccine design
2019 · Ekaterina Stepanova, Irina Isakova-Sivak, et al. · Expert Review of Vaccines · 16
PDF
Truncation of NS1 Protein Enhances T Cell-Mediated Cross-Protection of a Live Attenuated Influenza Vaccine Virus Expressing Wild-Type Nucleoprotein
2023 · Polina Prokopenko, Victoria Matyushenko, et al. · Vaccines · 13
PDF
Understanding the Variability of Certain Biological Properties of H1N1pdm09 Influenza Viruses
2022 · Mohammad Al Farroukh, Irina Kiseleva, et al. · Vaccines · 13
PDF
Cross-Protective Efficacy of Monovalent Live Influenza B Vaccines against Genetically Different Lineages of B/Victoria and B/Yamagata in Ferrets
2018 · Irina Kiseleva, Elena Krutikova, et al. · BioMed Research International · 10
PDF
Development of Cross-Reactive Live Attenuated Influenza Vaccine Candidates against Both Lineages of Influenza B Virus
2024 · Pei-Fong Wong, Irina Isakova-Sivak, et al. · Vaccines · 9
PDF
Safety, Immunogenicity, and Protective Efficacy of a Chimeric A/B Live Attenuated Influenza Vaccine in a Mouse Model
2021 · Ekaterina Stepanova, Elena Krutikova, et al. · Microorganisms · 9
PDF
Expression of the SARS-CoV-2 receptor-binding domain by live attenuated influenza vaccine virus as a strategy for designing a bivalent vaccine against COVID-19 and influenza
2024 · Ekaterina Stepanova, Irina Isakova-Sivak, et al. · Virology Journal · 8
PDF
Generation of a Vaccine against Group B Streptococcal Infection on the Basis of a Cold-Adapted Influenza A Virus
2019 · T. A. Smolonogina, I. N. Isakova-Sivak, et al. · Molecular Genetics Microbiology and Virology · 8
Two Live Attenuated Vaccines against Recent Low–and Highly Pathogenic H7N9 Influenza Viruses Are Safe and Immunogenic in Ferrets
2018 · Larisa Rudenko, Irina Kiseleva, et al. · Vaccines · 8
PDF
Safety, Immunogenicity and Protective Activity of a Modified Trivalent Live Attenuated Influenza Vaccine for Combined Protection Against Seasonal Influenza and COVID-19 in Golden Syrian Hamsters
2024 · Ekaterina Stepanova, Victoria Matyushenko, et al. · Vaccines · 7
Safety and Immunogenicity Study of a Bivalent Vaccine for Combined Prophylaxis of COVID-19 and Influenza in Non-Human Primates
2024 · Ekaterina Stepanova, Irina Isakova-Sivak, et al. · Vaccines · 7
PDF
Options for the development of a bivalent vaccine against SARS-CoV-2 and influenza
2022 · Ekaterina Stepanova, Irina Isakova-Sivak, et al. · Expert Review of Vaccines · 7
PDF
A Phase 1 Randomized Placebo-Controlled Study to Assess the Safety, Immunogenicity and Genetic Stability of a New Potential Pandemic H7N9 Live Attenuated Influenza Vaccine in Healthy Adults
2020 · Irina Kiseleva, Irina Isakova-Sivak, et al. · Vaccines · 7
PDF
Amino Acid Substitutions N123D and N149D in Hemagglutinin Molecule Enhance Immunigenicity of Live Attenuated Influenza H7N9 Vaccine Strain in Experiment
2019 · E. A. Stepanova, T. S. Kotomina, et al. · Bulletin of Experimental Biology and Medicine · 7
Neutralizing epitope of the Fusion Protein of Respiratory Syncytial Virus Embedded in the HA Molecule of LAIV Virus is not Sufficient to Prevent RS Virus Pulmonary Replication but Ameliorates Lung Pathology following RSV Infection in Mice
2020 · Tatiana Kotomina, Irina Isakova-Sivak, et al. · The Open Microbiology Journal · 6
PDF
Neuraminidase Antibody Response to Homologous and Drifted Influenza A Viruses After Immunization with Seasonal Influenza Vaccines
2024 · Yulia Desheva, Maria Sergeeva, et al. · Vaccines · 5
PDF
In vitro antiviral activity of VIFERON® rectal suppositories against SARS-CoV-2
2022 · I. N. Isakova-Sivak, E. A. Stepanova, et al. · Russian Journal of Infection and Immunity · 3
PDF
Optimized properties of live vaccine influenza reassortant strains obtained by reverse genetics
2024 · N. V. Larionova, I. V. Kiseleva, et al. · Russian Journal of Infection and Immunity · 2
PDF
Works count: 56
Citation count: 329
H-index: 10
I10-index: 11
Year
Topic
Type